/PRNewswire/ DRASTIC Investigator Gilles Demaneuf and Physician-Scientist Dr. Steven C. Quay, M.D., Ph.D., CEO of Atossa Therapeutics (NASDAQ: ATOS), have.
/PRNewswire/ Physician-Scientist Dr. Steven C. Quay, M.D., Ph.D., CEO of Atossa Therapeutics (NASDAQ: ATOS) has been asked to brief the elected members and.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
COVID-19 Origin and Spread Linked to PLA Hospital and Wuhan Metro System Line 2 by Physician-Scientist Dr. Steven Quay
January 8, 2021 GMT
HOUSTON, Jan. 8, 2021 /PRNewswire/ Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS ), recently shared his latest research and findings regarding the origins of COVID-19 and the manner in which it spread so quickly.
He says that looking at the origins of the virus is crucial in order to fully understand how it infects humans and to develop better treatments. Dr. Quay said that “in investigating that process, I found an unusual pattern in what’s called a genetic cluster.” He goes on to say that there were four patients with “literally the same virus, or only a tiny number of changes that represent the first version of the virus, SARS-CoV-2, that entered humans.
/PRNewswire/ Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. (NASDAQ: ATOS ), recently shared his latest.